Agilent Technologies, Inc. - Diagnostics and Genomics SSXT CD GlasgowCancerCore, 96
The Agilent SureSelectXT Custom DNA Panel, CD GlasgowCancerCore (96 reactions), part number 5191-6730, is designed for targeted next-generation sequencing (NGS) applications. This panel enables researchers to capture and enrich specific genomic regions of interest, facilitating high-sensitivity detection of genetic variants associated with cancer research. The SureSelectXT workflow provides robust performance with high specificity and uniformity, supporting efficient library preparation and target enrichment from genomic DNA samples. The kit is optimized for use with Illumina sequencing platforms and includes reagents for 96 reactions.